These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 31761193)
21. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy. Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645 [TBL] [Abstract][Full Text] [Related]
22. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer. Mi Y; Zhao J; Feng SS J Control Release; 2013 Aug; 169(3):185-92. PubMed ID: 23403395 [TBL] [Abstract][Full Text] [Related]
23. Vascular targeted chitosan-derived nanoparticles as docetaxel carriers for gastric cancer therapy. Zhang E; Xing R; Liu S; Li K; Qin Y; Yu H; Li P Int J Biol Macromol; 2019 Apr; 126():662-672. PubMed ID: 30599159 [TBL] [Abstract][Full Text] [Related]
24. pH-sensitive dual drug loaded janus nanoparticles by oral delivery for multimodal analgesia. Liu L; Yao W; Xie X; Gao J; Lu X J Nanobiotechnology; 2021 Aug; 19(1):235. PubMed ID: 34362394 [TBL] [Abstract][Full Text] [Related]
25. Dissolution and bioavailability of lercanidipine-hydroxypropylmethyl cellulose nanoparticles with surfactant. Ha ES; Choo GH; Baek IH; Kim JS; Cho W; Jung YS; Jin SE; Hwang SJ; Kim MS Int J Biol Macromol; 2015 Jan; 72():218-22. PubMed ID: 25159878 [TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel. Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431 [TBL] [Abstract][Full Text] [Related]
27. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations. Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431 [TBL] [Abstract][Full Text] [Related]
28. Sodium Dodecyl Sulfate-Modified Doxorubicin-Loaded Chitosan-Lipid Nanocarrier with Multi Polysaccharide-Lecithin Nanoarchitecture for Augmented Bioavailability and Stability of Oral Administration In Vitro and In Vivo. Su CW; Chiang MY; Lin YL; Tsai NM; Chen YP; Li WM; Hsu CH; Chen SY J Biomed Nanotechnol; 2016 May; 12(5):962-72. PubMed ID: 27305818 [TBL] [Abstract][Full Text] [Related]
29. Nanoparticles from Gantrez® AN-poly(ethylene glycol) conjugates as carriers for oral delivery of docetaxel. Ruiz-Gatón L; Espuelas S; Huarte J; Larrañeta E; Martin-Arbella N; Irache JM Int J Pharm; 2019 Nov; 571():118699. PubMed ID: 31536764 [TBL] [Abstract][Full Text] [Related]
30. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery. Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048 [TBL] [Abstract][Full Text] [Related]
31. Aspartic acid tagged carbon nanotubols as a tool to deliver docetaxel to breast cancer cells: Reduced hemotoxicity with improved cytotoxicity. Thotakura N; Sharma S; Khurana RK; Babu PV; Chitkara D; Kumar V; Singh B; Raza K Toxicol In Vitro; 2019 Sep; 59():126-134. PubMed ID: 30986424 [TBL] [Abstract][Full Text] [Related]
32. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery. Rafiei P; Haddadi A Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109950. PubMed ID: 31499976 [TBL] [Abstract][Full Text] [Related]
33. Rational design of polymer-lipid nanoparticles for docetaxel delivery. Albano JMR; Ribeiro LNM; Couto VM; Barbosa Messias M; Rodrigues da Silva GH; Breitkreitz MC; de Paula E; Pickholz M Colloids Surf B Biointerfaces; 2019 Mar; 175():56-64. PubMed ID: 30517905 [TBL] [Abstract][Full Text] [Related]
34. Chitosan nanoparticle antigen uptake in epithelial monolayers can predict mucosal but not systemic in vivo immune response by oral delivery. Cole H; Bryan D; Lancaster L; Mawas F; Vllasaliu D Carbohydr Polym; 2018 Jun; 190():248-254. PubMed ID: 29628245 [TBL] [Abstract][Full Text] [Related]
35. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance. Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050 [TBL] [Abstract][Full Text] [Related]
36. TPGS-chitosan cross-linked targeted nanoparticles for effective brain cancer therapy. Agrawal P; Singh RP; Sonali ; Kumari L; Sharma G; Koch B; Rajesh CV; Mehata AK; Singh S; Pandey BL; Muthu MS Mater Sci Eng C Mater Biol Appl; 2017 May; 74():167-176. PubMed ID: 28254282 [TBL] [Abstract][Full Text] [Related]
37. Amorphous ternary nanoparticle complex of curcumin-chitosan-hypromellose exhibiting built-in solubility enhancement and physical stability of curcumin. Lim LM; Tran TT; Long Wong JJ; Wang D; Cheow WS; Hadinoto K Colloids Surf B Biointerfaces; 2018 Jul; 167():483-491. PubMed ID: 29727835 [TBL] [Abstract][Full Text] [Related]
38. Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug, Docetaxel. Zhang Y; Zhu W; Zhang H; Han J; Zhang L; Lin Q; Ai F Int J Pharm; 2017 Oct; 532(1):384-392. PubMed ID: 28903067 [TBL] [Abstract][Full Text] [Related]
39. Rapamycin loaded TPGS-Lecithins-Zein nanoparticles based on core-shell structure for oral drug administration. Xie Z; Zhang Z; Lv H Int J Pharm; 2019 Sep; 568():118529. PubMed ID: 31323368 [TBL] [Abstract][Full Text] [Related]
40. The efficiency and mechanism of a new absorption enhancer, malic acid, for enhancing the oral bioavailability of docetaxel. Guo XH; Ding F; Lian X; Cui W; Li Z; Xing Y Pharm Dev Technol; 2021 Jun; 26(5):592-598. PubMed ID: 33734909 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]